SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Axcan Pharma Inc. (AXP) -- Ignore unavailable to you. Want to Upgrade?

To: Jarrod W. Pakosh who wrote (4)8/3/1999 12:36:00 PM
From: LAURIE SELINE  Read Replies (1) | Respond to of 14
 
Jarrod: Apparently they have Scandipharm at $8.85 making this (get this) the only Canadian pharma with a U.S. salesforce. Apparently a good outfit and a good fit. Where's Shwartz in all this?
Anyway, good to see some positive movement.
Regards,
L.



To: Jarrod W. Pakosh who wrote (4)8/18/2000 8:20:59 AM
From: Arthur Radley  Respond to of 14
 
Now that Axcan is traded on the NASDAQ, I have started a new thread here on SI....I would welcome your comments there. Needless to say, I think AXCA is a great buy at these levels....especially with the news coming soon on their pipeline of potential drugs..http://www.siliconinvestor.com/subject.aspx?subjectid=36596


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News